Comparing drug combinations for lymphatic filariasis
Part of Blood & lymphatic, Infections, Skin clinical trials.
This study compares two different medicine combinations given to entire communities to treat and prevent lymphatic filariasis (a parasitic infection that causes swelling). The goal is to find a better way to deliver these medicines to reduce the disease in affected areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in one of the study areas.
- You must be willing to give signed consent (agree to join).
- You must not have a severe illness that prevents daily activities.
- You must not be allergic to any of the study drugs (ivermectin, moxidectin, diethylcarbamazine, or albendazole).
- If you are pregnant, or breastfeeding a baby younger than 7 days, you cannot receive the treatment.
- For treatment: children must be at least 4 years old (for one drug combo) or at least 2 years old and 15 kg (for another combo).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if moxidectin works better than ivermectin for controlling river blindness and other neglected tropical diseases. Both drugs are given as a single dose during mass treatment campaigns in villages.
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
This study tests different combinations of medicines to treat whipworm infection in children. It aims to find the best way to clear the infection and improve children's health.
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
This study looks at how the body's immune system reacts to filarial infections—parasitic worms that affect millions worldwide. Researchers will observe your infection and response to treatment to better understand the disease and improve future care.
This trial is testing the drug albendazole in people who have Loa loa, a worm infection that can cause itchy swellings. The study will see if a 21-day course of albendazole helps clear the infection better than a placebo.
Hear when a new Lymphatic Filariasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.